Buscar

Estamos realizando la búsqueda. Por favor, espere...

Faecal microbiota transplantation, paving the way to treat non-alcoholic fatty liver disease

Abstract: Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent cause of chronic liver disease (CLD). Currently, the only therapeutic recommendation available is a lifestyle change. However, adherence to this approach is often difficult to guarantee. Alteration of the microbiota and an increase in intestinal permeability seem to be key in the development and progression of NAFLD. Therefore, the manipulation of microbiota seems to provide a promising therapeutic strategy. One way to do so is through faecal microbiota transplantation (FMT). Here, we summarize the key aspects of FMT, detail its current indications and highlight the most recent advances in NAFLD

 Fuente: International journal of molecular sciences, 2023, 24(7), 6123

 Editorial: MPDI

 Año de publicación: 2023

 Nº de páginas: 19

 Tipo de publicación: Artículo de Revista

 DOI: 10.3390/ijms24076123

 ISSN: 1661-6596,1422-0067

 Url de la publicación: https://doi.org/10.3390/ ijms24076123

Autoría

BARRIO, MARÍA DEL

LAVÍN, LUCÍA

SANTOS-LASO, ÁLVARO

ODRIOZOLA, AITOR

RODRIGUEZ-DUQUE, JUAN CARLOS

RIVAS, CORAL

IRUZUBIETA, PAULA